166 related articles for article (PubMed ID: 30204052)
21. Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout.
Steimbach RR; Herbst-Gervasoni CJ; Lechner S; Stewart TM; Klinke G; Ridinger J; Géraldy MNE; Tihanyi G; Foley JR; Uhrig U; Kuster B; Poschet G; Casero RA; Médard G; Oehme I; Christianson DW; Gunkel N; Miller AK
J Am Chem Soc; 2022 Oct; 144(41):18861-18875. PubMed ID: 36200994
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitors.
Lambona C; Zwergel C; Fioravanti R; Valente S; Mai A
Curr Opin Struct Biol; 2023 Oct; 82():102668. PubMed ID: 37542907
[TBL] [Abstract][Full Text] [Related]
23. Identification of potent HDAC 2 inhibitors using E-pharmacophore modelling, structure-based virtual screening and molecular dynamic simulation.
Pai P; Kumar A; Shetty MG; Kini SG; Krishna MB; Satyamoorthy K; Babitha KS
J Mol Model; 2022 Apr; 28(5):119. PubMed ID: 35419753
[TBL] [Abstract][Full Text] [Related]
24. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing.
Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W
J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors.
Reddy DR; Ballante F; Zhou NJ; Marshall GR
Eur J Med Chem; 2017 Feb; 127():531-553. PubMed ID: 28109947
[TBL] [Abstract][Full Text] [Related]
26. Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoforms.
Ganai SA; Shanmugam K; Mahadevan V
J Biomol Struct Dyn; 2015; 33(2):374-87. PubMed ID: 24460542
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for the design and synthesis of selective HDAC inhibitors.
Di Micco S; Chini MG; Terracciano S; Bruno I; Riccio R; Bifulco G
Bioorg Med Chem; 2013 Jul; 21(13):3795-807. PubMed ID: 23693069
[TBL] [Abstract][Full Text] [Related]
28. Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.
Shinsky SA; Christianson DW
Biochemistry; 2018 Jun; 57(22):3105-3114. PubMed ID: 29533602
[TBL] [Abstract][Full Text] [Related]
29. Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors.
Park H; Lee S
J Comput Aided Mol Des; 2004 Jun; 18(6):375-88. PubMed ID: 15662999
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of mammalian HDAC10, a novel histone deacetylase.
Kao HY; Lee CH; Komarov A; Han CC; Evans RM
J Biol Chem; 2002 Jan; 277(1):187-93. PubMed ID: 11677242
[TBL] [Abstract][Full Text] [Related]
31. X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10.
Herbst-Gervasoni CJ; Christianson DW
Biochemistry; 2021 Feb; 60(4):303-313. PubMed ID: 33449614
[TBL] [Abstract][Full Text] [Related]
32. Structure-based virtual screening for novel potential selective inhibitors of class IIa histone deacetylases for cancer treatment.
Elmezayen AD; Kemal Y
Comput Biol Chem; 2021 Jun; 92():107491. PubMed ID: 33930743
[TBL] [Abstract][Full Text] [Related]
33. Exploring inhibitor release pathways in histone deacetylases using random acceleration molecular dynamics simulations.
Kalyaanamoorthy S; Chen YP
J Chem Inf Model; 2012 Feb; 52(2):589-603. PubMed ID: 22263580
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors.
Kashyap K; Kakkar R
Comput Biol Med; 2020 Aug; 123():103850. PubMed ID: 32658783
[TBL] [Abstract][Full Text] [Related]
35. In Silico Identification of Potential Inhibitor Against a Fungal Histone Deacetylase, RPD3 from
Shanmugam G; Kim T; Jeon J
Molecules; 2019 May; 24(11):. PubMed ID: 31151320
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.
Singh R; Pandey PN
Mol Biol Rep; 2015 Mar; 42(3):689-98. PubMed ID: 25663090
[TBL] [Abstract][Full Text] [Related]
37. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain.
Tong JJ; Liu J; Bertos NR; Yang XJ
Nucleic Acids Res; 2002 Mar; 30(5):1114-23. PubMed ID: 11861901
[TBL] [Abstract][Full Text] [Related]
38. QSAR modeling to design selective histone deacetylase 8 (HDAC8) inhibitors.
Cao GP; Thangapandian S; Son M; Kumar R; Choi YJ; Kim Y; Kwon YJ; Kim HH; Suh JK; Lee KW
Arch Pharm Res; 2016 Oct; 39(10):1356-1369. PubMed ID: 27542119
[TBL] [Abstract][Full Text] [Related]
39. Insights into intermolecular interactions, electrostatic properties and the stability of C646 in the binding pocket of p300 histone acetyltransferase enzyme: a combined molecular dynamics and charge density study.
Sivanandam M; Saravanan K; Kumaradhas P
J Biomol Struct Dyn; 2018 Sep; 36(12):3246-3264. PubMed ID: 28948877
[TBL] [Abstract][Full Text] [Related]
40. Phenolic compounds as histone deacetylase inhibitors: binding propensity and interaction insights from molecular docking and dynamics simulations.
Uba AI; Zengin G
Amino Acids; 2023 May; 55(5):579-593. PubMed ID: 36781452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
